Advanced Biomed Inc.
ADVB
ADVB
Nasdaq
Health Technology
Biotechnology
3.98
USD-0.9
-18.44%
Closed: 10-16 20:00 (UTC+0)
3.98
USD+0.79
+19.85%
After Hours: 10-17 00:00 (UTC+0)
ADVB Key Statistics
High
4.70
Open
4.69
Volume
28.27K
Low
3.69
Prev. Close
4.88
Trading Value
115.16K
52-Week High
24.23
Relative Volume
1.97
Amplitude (%)
20.62%
52-Week Low
3.61
Turnover Rate
1.71%
Market Cap
6.57M
P/E Ratio (TTM)
--
P/E Ratio (Annual)
0.747
P/B Ratio
0.54
P/S Ratio
51.52
Earnings Per Share (EPS)
-0.08
Dividend (TTM)
0
Dividend Yield
0.00%
Shares Outstanding
1.65M
Currency Unit
USD
ADVB Price Performance
7 day
30 day
90 day
180 day
Year to date
1 Year
ADVB Money Flow Distribution
ADVB Daily Short Sale Volume
ADVB Short Interest History
ADVB Stock Snapshot
As of 2026-10-17, the Advanced Biomed Inc. (ADVB) stock price today is 3.98. Based on this price, the company has a market capitalization of $6.57M, with a P/E ratio of --.
On 2026-10-17, ADVB traded between 3.69 and 4.70. Today’s stock price is 7.86% above the daily low and 15.32% below the daily high, placing ADVB in the lower range of its most recent trading range.
Trading volume currently stands at 28.27K, compared with an average daily volume of 14.35K. This suggests that trading activity is significantly above its usual level than usual.
Over the past year, Advanced Biomed Inc. shares have traded between 3.61 and 24.23. At today’s price, ADVB is 10.25% above its 52-week low and 83.57% below its 52-week high.
ADVB Related News
About ADVB
Company Name
Advanced Biomed Inc.
Sector
Health Technology
Industry
Biotechnology
Exchanges
Nasdaq
Number of Employees
12
Lot Size
100
Official Website
Currency Unit
USD
Advanced Biomed Inc. (ADVB) is a medical-technology company that develops microfluidic biochip technologies and precision cancer-diagnosis and treatment applications through its subsidiaries. By combining semiconductor and biotechnology methods, it has created systems for cancer screening, detection, diagnosis, staging, and treatment support. Devices include A+Pre, AC-1000, A+CellScan, and A+SCDrop, supported by A+Pre, AC-1000 CTC Enrichment, and A+CellScan microfluidic chips, with the goal of providing rapid and affordable assays for cancer patients.
ADVB FAQ
© 2026 CoinGlass, all rights reserved
